- Home
- NNNN vs SYBT Comparison
NNNN vs SYBT Comparison
Compare NNNN & SYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- SYBT
- Stock Information
- Founded
- NNNN 2021
- SYBT 1904
- Country
- NNNN Germany
- SYBT United States
- Employees
- NNNN N/A
- SYBT N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SYBT Major Banks
- Sector
- NNNN Health Care
- SYBT Finance
- Exchange
- NNNN Nasdaq
- SYBT Nasdaq
- Market Cap
- NNNN 2.2B
- SYBT 2.1B
- IPO Year
- NNNN 2025
- SYBT N/A
- Fundamental
- Price
- NNNN $23.92
- SYBT $67.50
- Analyst Decision
- NNNN
- SYBT Hold
- Analyst Count
- NNNN 0
- SYBT 3
- Target Price
- NNNN N/A
- SYBT $83.67
- AVG Volume (30 Days)
- NNNN 76.5K
- SYBT 113.3K
- Earning Date
- NNNN 11-07-2025
- SYBT 10-24-2025
- Dividend Yield
- NNNN N/A
- SYBT 1.88%
- EPS Growth
- NNNN N/A
- SYBT 22.18
- EPS
- NNNN 0.06
- SYBT 4.35
- Revenue
- NNNN $8,185,146.00
- SYBT $364,546,000.00
- Revenue This Year
- NNNN N/A
- SYBT $16.82
- Revenue Next Year
- NNNN N/A
- SYBT $5.11
- P/E Ratio
- NNNN $442.46
- SYBT $15.52
- Revenue Growth
- NNNN 21.95
- SYBT 11.32
- 52 Week Low
- NNNN $5.18
- SYBT $60.75
- 52 Week High
- NNNN $55.65
- SYBT $83.83
- Technical
- Relative Strength Index (RSI)
- NNNN 35.64
- SYBT 43.27
- Support Level
- NNNN $26.05
- SYBT $66.13
- Resistance Level
- NNNN $30.65
- SYBT $68.63
- Average True Range (ATR)
- NNNN 2.72
- SYBT 2.01
- MACD
- NNNN -0.11
- SYBT 0.24
- Stochastic Oscillator
- NNNN 19.80
- SYBT 44.55
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About SYBT Stock Yards Bancorp Inc.
Stock Yards Bancorp Inc operates as a bank. The bank has two reportable operating segments namely Commercial Banking and Wealth Management and Trust. Its services include loan and deposit services, cash management services, securities brokerage activities, mortgage origination, and others. It generates the majority of its revenue from the Commercial Banking segment.